Home
Clinical Resources Search
PQI: Ruxolitinib (Jakafi®): Managing Myelofibrosis Patients

Ruxolitinib (Jakafi®): Managing Myelofibrosis Patients

Download PQI pdf

Last Updated: April 29, 2024

By: Todd Murphree, PharmD

About this PQI

Ruxolitinib is a selective JAK2 inhibitor used for the treatment of myelofibrosis (MF). This PQI will review the close monitoring of platelets required to ensure appropriate dose and avoid severe thrombocytopenia due to the therapy.

More About This PQI

PQI:

Ruxolitinib-Jakafi-Managing-Treatment-of-Polycythemia-Vera_PQI_NCODA pdf

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Ruxolitinib (Jakafi®): Managing Myelofibrosis Patients

About this PQI

More About This PQI

PQI:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E3: Beyond Borders: Bringing Cancer Treatment Within Reach

S11 E2: Navigating Life After Cancer

S11 E1: Fail First, Patients Last? Rethinking Step Therapy in Oncology

S10 E15: From Student to Fellow to Leader: Exploring Pharmacy Fellowships

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Avutometinib and Defactinib

Treatment Support Kit: Mirdametinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S7 Ep 8: Sickle Cell Disease Insights

Pacritinib

Hydroxyurea

Momelotinib

Ruxolitinib

Ruxolitinib

PQI in Action: Ropeginterferon alfa-2b-njft (BESREMi®) Use in Polycythemia Vera

PQI: Ruxolitinib (Jakafi®): Managing Treatment of Polycythemia Vera

Ruxolitinib

PQI in Action: Extolling the Benefits of Identifying Polycythemia Vera Patients and Myelofibrosis within Medically Integrated Dispensing Practices

PQI: Ruxolitinib (Jakafi®): Managing Treatment of Polycythemia Vera

Ruxolitinib

PQI in Action: Extolling the Benefits of Identifying Polycythemia Vera Patients and Myelofibrosis within Medically Integrated Dispensing Practices

S11 E3: Beyond Borders: Bringing Cancer Treatment Within Reach

Dordaviprone

Dactinomycin

Cyclosporine